Loading...
XNASINGN
Market cap204mUSD
Dec 27, Last price  
8.58USD
1D
-0.23%
1Q
-11.46%
Jan 2017
-87.23%
IPO
-43.74%
Name

Inogen Inc

Chart & Performance

D1W1MN
XNAS:INGN chart
P/E
—
P/S
0.65
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
0.58%
Rev. gr., 5y
-2.49%
Revenues
316m
-16.32%
30,634,00048,576,00075,443,000112,537,000159,005,000202,829,000249,438,000358,111,000361,943,000308,487,000358,003,000377,241,000315,660,000
Net income
-102m
L+22.30%
-2,002,000564,00025,435,0006,826,00011,585,00020,519,00021,002,00051,845,00020,950,000-5,829,000-6,333,000-83,772,000-102,449,000
CFO
-3m
L-91.38%
1,859,0004,004,00013,467,00015,697,00038,161,00031,034,00060,494,00059,977,00040,593,00037,013,00023,633,000-37,532,000-3,234,000
Earnings
Feb 25, 2025

Profile

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
URL
https://www.inogen.com/
IPO date
Feb 14, 2014
Employees
1,026
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
315,660
-16.32%
377,241
5.37%
358,003
16.05%
Cost of revenue
392,152
410,323
348,763
Unusual Expense (Income)
NOPBT
(76,492)
(33,082)
9,240
NOPBT Margin
2.58%
Operating Taxes
105
504
14,992
Tax Rate
162.25%
NOPAT
(76,597)
(33,586)
(5,752)
Net income
(102,449)
22.30%
(83,772)
1,222.79%
(6,333)
8.65%
Dividends
Dividend yield
Proceeds from repurchase of equity
960
380
15,000
BB yield
-0.75%
-0.08%
-1.96%
Debt
Debt current
7,306
3,515
3,393
Long-term debt
40,193
43,043
49,955
Deferred revenue
8,227
10,399
11,861
Other long-term liabilities
13,850
12,123
15,386
Net debt
(80,972)
(140,456)
(177,721)
Cash flow
Cash from operating activities
(3,234)
(37,532)
23,633
CAPEX
(26,517)
(21,222)
(24,067)
Cash from investing activities
(59,315)
(10,877)
(14,645)
Cash from financing activities
960
380
15,000
FCF
(39,965)
(64,913)
(38,388)
Balance
Cash
128,471
187,014
245,513
Long term investments
(14,444)
Excess cash
112,688
168,152
213,169
Stockholders' equity
(115,701)
(14,720)
70,764
Invested Capital
368,166
357,435
353,309
ROIC
ROCE
2.14%
EV
Common stock shares outstanding
23,176
22,853
22,490
Price
5.49
-72.15%
19.71
-42.03%
34.00
-23.90%
Market cap
127,237
-71.75%
450,424
-41.09%
764,661
-22.14%
EV
46,265
309,968
586,940
EBITDA
(58,340)
(9,568)
30,868
EV/EBITDA
19.01
Interest
2,837
Interest/NOPBT